Oligosaccharides having anti-Xa activity, pharmaceutical composi

Details Oligosaccharides having anti-Xa activity, pharmaceutical composi Oligosaccharides having anti-Xa activity, pharmaceutical composi

1983-08-22

1984-10-02

Brown, Johnnie R.

Drug, bio-affecting and body treating compositions

Conjugate or complex of monoclonal or polyclonal antibody,...

Conjugated to proteinaceous toxin or fragment thereof

536 21, A61K 31725, C08B 3710

Patent

active

044747705

ABSTRACT:
Oligosaccharides obtainable from heparin including heparinic constituents of molecular weights ranging from 2000 to 50,000. Said fractions have a Yin-Wessler titer and a U.S.P. titer in a ratio of at least 30.
They consist of chains constituted by no more than 8 saccharidic moities. They possess a strong antithrombotic activity and are then useful as antithrombotic drugs.

REFERENCES:
patent: 4281108 (1981-07-01), Fussi
patent: 4401662 (1983-08-01), Lormeau et al.
patent: 4401758 (1983-08-01), Lormeau et al.

Affiliated with

Also associated with

Rating

Oligosaccharides having anti-Xa activity, pharmaceutical composi does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oligosaccharides having anti-Xa activity, pharmaceutical composi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oligosaccharides having anti-Xa activity, pharmaceutical composi will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-526438